Financial Services Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Financial Services Advisory's XBI Position: Q3 2026 in Review
Financial Services Advisory sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 3,829 shares — an estimated $606K sold.
Financial Services Advisory first reported a position in XBI in Q2 2023 and held it in 3 quarters. The position peaked at $852K in Q4 2025. 959 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Financial Services Advisory reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
- Financial Services Advisory sold 3,829 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $606K.
- Financial Services Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and held it in 3 quarters.
- Financial Services Advisory's State Street SPDR S&P Biotech ETF position peaked at $852K in Q4 2025.
- 959 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Financial Services Advisory's 13F filing for Q3 2026, filed 26 Oct 2026.